Daily Digest: Cannabis and Anxiety Risk in the Long Run — March 03, 2026
This digest reviews new cohort data on cannabis and anxiety risk long term. While cannabis may offer short-term relief, sustained use shows complex anxiety outcomes. Dr. Caplan provides clinical context on these findings.
Daily Digest: Last 9 Hours: Cannabis and Anxiety Risk in the Long Run — March 02, 2026
This digest reviews a recent longitudinal study on cannabis and anxiety risk, emphasizing the dose-dependent relationship found. The evidence challenges the notion that cannabis reliably manages anxiety long-term. Clinical insights highlight the…
New Study Reveals Cannabis-Anxiety Relationships and Clinical Implications
This decade-long study provides new evidence on 2026 cannabis anxiety clinical findings crucial for clinical counseling. It highlights increased anxiety risks linked to regular cannabis use. Clinicians should consider these findings when advising…
Link between cannabis and anxiety, depression has ‘strengthened over time’: new study
This study highlights the growing evidence that cannabis use and mental health outcomes such as anxiety and depression are increasingly connected. The findings challenge common beliefs about cannabis as a self-medication tool. Clinicians should carefully…
Link Between Cannabis and Anxiety, Depression Strengthens Over Time
Recent studies reveal a strengthening cannabis anxiety link that challenges previous perceptions of cannabis as a benign anxiolytic. This evolving evidence suggests cannabis may exacerbate mood disorders like anxiety and depression. Clinicians should…
Study Finds Cannabis Use, Anxiety, and Depression Rising in Canada
A Canadian study highlights cannabis use anxiety treatment evidence by showing rising rates of cannabis use alongside anxiety and depression. The research reveals a consistent association between cannabis use and mood disorders. This evidence underscores…
Cannabis Use, Anxiety, and Depression Trends in Canada
Recent research highlights rising cannabis use alongside increased anxiety and depression in Canada. Cannabis use and mental health risks are complex, with high-THC products potentially worsening symptoms. Patients should seek medical guidance on…
The Week in Weed: February 27, 2026 – Lexology Insights
Acute cannabis effects include perceptual, cardiovascular, and cognitive changes that are time-limited but clinically important. Understanding these effects helps clinicians counsel patients effectively during therapy initiation. This knowledge supports…
Nebraska Bill Seeks to Shield Doctors Recommending Medical Cannabis
The Nebraska medical cannabis program is progressing with legislation aimed at protecting physicians who recommend cannabis. This legal protection removes barriers for doctors, allowing them to provide evidence-based recommendations without fear of…
“Mother of Cannabinoids”: The Rising Potential of CBG and CBG-A
Cannabigerol anxiety cognitive symptoms are gaining attention as potential targets for new cannabinoid therapies. Patients not responding to CBD or THC may find promise in CBG formulations. Clinical evidence is preliminary but growing in this area.